Transoral Robotic Supraglottic Laryngectomy in Laryngeal Squamous Cell Carcinoma

doi:10.13188/2380-0569.1000021

Abstract

The most common histological type of laryngeal cancer is squamous cell carcinoma, and the supraglottic and glottic regions are the most common sites of this type. Supraglottic laryngectomy is the most common treatment in supraglottic squamous cell carcinoma. Recently, robotic surgery has become widespread in laryngeal surgery. This review summarizes publications on Transoral Robotic Supraglottic Laryngectomy (TORSL).

Highlights

Laryngeal cancer represents 2% to 5% of all malignancies and 20% to 25% of all head and neck tumors [1]
In 2005, Weinstein et al reported on Transoral Robotic Supraglottic Laryngectomy (TORSL) [4]
There are rules about which patients can be treated with TORSL, there are different indications in some cases

Summary

Introduction

Laryngeal cancer represents 2% to 5% of all malignancies and 20% to 25% of all head and neck tumors [1]. An open total laryngectomy was performed for laryngeal squamous cell carcinoma This practice subsequently declined and the use of open technical partial laryngectomy increased. Endoscopic and laser microsurgery methods have begun to be applied These methods are advantageous because they use the natural openings of the body, reach directly through the laryngeal structures, and cause minimal damage to surrounding tissues. The use of the da Vinci robotic system (Intuitive, Sunnyvale, CA, USA) in head and neck surgery has furthered these developments. In 2005, Weinstein et al reported on Transoral Robotic Supraglottic Laryngectomy (TORSL) [4] Another robotic system, the Medrobotics Flex Robotic System (Medrobotics, Raynham, MA, USA), received approval for head and neck surgery in 2015 [3]

Preoperative Evaluation and Patient Selection

Mazlumoglu MR*

Findings

Surgical Technique